Terms: = Bone cancer AND CCND2, KIAK0002, 894, ENSG00000118971, P30279, MGC102758 AND Treatment
27 results:
1. Progression before local control in osteosarcoma: Outcome and prognosis-predictive factors.
Halalsheh H; Amer S; Sultan I
Pediatr Blood Cancer; 2023 Nov; 70(11):e30649. PubMed ID: 37638816
[TBL] [Abstract] [Full Text] [Related]
2. Assessment of bone-targeting agents use in patients with bone metastasis from breast, lung or prostate cancer using structured and unstructured electronic health records from a regional UK-based hospital.
Seesaghur A; Egger P; Warden J; Abbasi A; Levick B; Riaz M; McMahon P; Thompson M; Cheeseman S
BMJ Open; 2023 May; 13(5):e069214. PubMed ID: 37156580
[TBL] [Abstract] [Full Text] [Related]
3. MSH-5: malignant knee tumors timely detection index.
Rivera-Saldívar G; Torres-González R; Cario-Méndez A; Técualt-Gómez R; Amaya-Zepeda RA; Alcántara-Corona A; Fuentes-Figueroa S
Cir Cir; 2023; 91(2):146-152. PubMed ID: 37084299
[TBL] [Abstract] [Full Text] [Related]
4. Osteosarcoma with cell-cycle and fibroblast growth factor genomic alterations: case report of Molecular Tumor Board combination strategy resulting in long-term exceptional response.
Persha HE; Kato S; De P; Adashek JJ; Sicklick JK; Subbiah V; Kurzrock R
J Hematol Oncol; 2022 Aug; 15(1):119. PubMed ID: 36031605
[TBL] [Abstract] [Full Text] [Related]
5. Targeting the oncogenic transcription factor c-Maf for the treatment of multiple myeloma.
Jiang Q; Mao H; He G; Mao X
Cancer Lett; 2022 Sep; 543():215791. PubMed ID: 35700821
[TBL] [Abstract] [Full Text] [Related]
6. The cumulative incidence of cisplatin-induced hearing loss in young children is higher and develops at an early stage during therapy compared with older children based on 2052 audiological assessments.
Meijer AJM; Li KH; Brooks B; Clemens E; Ross CJ; Rassekh SR; Hoetink AE; van Grotel M; van den Heuvel-Eibrink MM; Carleton BC
Cancer; 2022 Jan; 128(1):169-179. PubMed ID: 34490624
[TBL] [Abstract] [Full Text] [Related]
7. Targeting
Kamseng P; Siriboonpiputtana T; Puavilai T; Chuncharunee S; Paisooksantivatana K; Chareonsirisuthigul T; Junking M; Chiraphapphaiboon W; Yenchitsomanus PT; Rerkamnuaychoke B
Pathol Oncol Res; 2021; 27():606567. PubMed ID: 34257568
[TBL] [Abstract] [Full Text] [Related]
8. Persistence of Drug-Resistant Leukemic Stem Cells and Impaired NK Cell Immunity in CML Patients Depend on
Silvestri G; Trotta R; Stramucci L; Ellis JJ; Harb JG; Neviani P; Wang S; Eisfeld AK; Walker CJ; Zhang B; Srutova K; Gambacorti-Passerini C; Pineda G; Jamieson CHM; Stagno F; Vigneri P; Nteliopoulos G; May PC; Reid AG; Garzon R; Roy DC; Moutuou MM; Guimond M; Hokland P; Deininger MW; Fitzgerald G; Harman C; Dazzi F; Milojkovic D; Apperley JF; Marcucci G; Qi J; Polakova KM; Zou Y; Fan X; Baer MR; Calabretta B; Perrotti D
Blood Cancer Discov; 2020 Jul; 1(1):48-67. PubMed ID: 32974613
[TBL] [Abstract] [Full Text] [Related]
9. Retrospective analysis of plasmacytoma in Kansai Myeloma Forum Registry.
Nakaya A; Tanaka H; Yagi H; Ohta K; Shibayama H; Kohara T; Kanda J; Shindo M; Shimura Y; Kosugi S; Kida T; Kaneko H; Imada K; Karasuno T; Matsuda M; Iida M; Adachi Y; Fuchida SI; Uoshima N; Uchiyama H; Takahashi R; Matsui T; Wada K; Kiyota M; Shimazaki C; Hino M; Kuroda J; Kanakura Y; Takaori-Kondo A; Nomura S; Matsumura I;
Int J Hematol; 2020 Nov; 112(5):666-673. PubMed ID: 32783165
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic value of platelet recovery degree before and after achieving minimal residual disease negative complete remission in acute myeloid leukemia patients.
Wang Y; Wang H; Wang W; Liu W; Liu N; Liu S; Lu Y
BMC Cancer; 2020 Aug; 20(1):732. PubMed ID: 32758189
[TBL] [Abstract] [Full Text] [Related]
11. Evaluation and improvement the safety of total marrow irradiation with helical tomotherapy using repeat failure mode and effects analysis.
Shen J; Wang X; Deng D; Gong J; Tan K; Zhao H; Bao Z; Xiao J; Liu A; Zhou Y; Liu H; Xie C
Radiat Oncol; 2019 Dec; 14(1):238. PubMed ID: 31882010
[TBL] [Abstract] [Full Text] [Related]
12. PRP‑1 significantly decreases the ALDHhigh cancer stem cell population and regulates the aberrant Wnt/β‑catenin pathway in human chondrosarcoma JJ012 cells.
Hoyt AK; Moran A; Granger C; Sedani A; Saigh S; Brown J; Galoian KA
Oncol Rep; 2019 Jul; 42(1):103-114. PubMed ID: 31180539
[TBL] [Abstract] [Full Text] [Related]
13. Effect of Conditioning Regimen Dose Reduction in Obese Patients Undergoing Autologous Hematopoietic Cell Transplantation.
Brunstein CG; Pasquini MC; Kim S; Fei M; Adekola K; Ahmed I; Aljurf M; Agrawal V; Auletta JJ; Battiwalla M; Bejanyan N; Bubalo J; Cerny J; Chee L; Ciurea SO; Freytes C; Gadalla SM; Gale RP; Ganguly S; Hashmi SK; Hematti P; Hildebrandt G; Holmberg LA; Lahoud OB; Landau H; Lazarus HM; de Lima M; Mathews V; Maziarz R; Nishihori T; Norkin M; Olsson R; Reshef R; Rotz S; Savani B; Schouten HC; Seo S; Wirk BM; Yared J; Mineishi S; Rogosheske J; Perales MA
Biol Blood Marrow Transplant; 2019 Mar; 25(3):480-487. PubMed ID: 30423481
[TBL] [Abstract] [Full Text] [Related]
14. MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial.
Dreno B; Thompson JF; Smithers BM; Santinami M; Jouary T; Gutzmer R; Levchenko E; Rutkowski P; Grob JJ; Korovin S; Drucis K; Grange F; Machet L; Hersey P; Krajsova I; Testori A; Conry R; Guillot B; Kruit WHJ; Demidov L; Thompson JA; Bondarenko I; Jaroszek J; Puig S; Cinat G; Hauschild A; Goeman JJ; van Houwelingen HC; Ulloa-Montoya F; Callegaro A; Dizier B; Spiessens B; Debois M; Brichard VG; Louahed J; Therasse P; Debruyne C; Kirkwood JM
Lancet Oncol; 2018 Jul; 19(7):916-929. PubMed ID: 29908991
[TBL] [Abstract] [Full Text] [Related]
15. CT colonography: size reduction of submerged colorectal polyps due to electronic cleansing and CT-window settings.
Bräuer C; Lefere P; Gryspeerdt S; Ringl H; Al-Mukhtar A; Apfaltrer P; Berzaczy D; Füger B; Furtner J; Müller-Mang C; Pones M; Scharitzer M; Woitek R; Graser A; Weber M; Mang T
Eur Radiol; 2018 Nov; 28(11):4766-4774. PubMed ID: 29761359
[TBL] [Abstract] [Full Text] [Related]
16. Serum Hepcidin Levels in Multiple Myeloma.
Victor M; Evgeniy H; Gergana T; Julia P; Vasil V; Borislav M; Ivo B; Zlatina G; Kamen T
Clin Lab; 2017 Jul; 63(7):1273-1277. PubMed ID: 28792693
[TBL] [Abstract] [Full Text] [Related]
17. Efficacy of two different doses of rabbit anti-T-lymphocyte globulin to prevent graft-versus-host disease in children with haematological malignancies transplanted from an unrelated donor: a multicentre, randomised, open-label, phase 3 trial.
Locatelli F; Bernardo ME; Bertaina A; Rognoni C; Comoli P; Rovelli A; Pession A; Fagioli F; Favre C; Lanino E; Giorgiani G; Merli P; Pagliara D; Prete A; Zecca M
Lancet Oncol; 2017 Aug; 18(8):1126-1136. PubMed ID: 28705454
[TBL] [Abstract] [Full Text] [Related]
18. miR-124 represses the mesenchymal features and suppresses metastasis in Ewing sarcoma.
Li Y; Shao G; Zhang M; Zhu F; Zhao B; He C; Zhang Z
Oncotarget; 2017 Feb; 8(6):10274-10286. PubMed ID: 28055964
[TBL] [Abstract] [Full Text] [Related]
19. RIC versus MAC UCBT in adults with AML: A report from Eurocord, the ALWP and the CTIWP of the EBMT.
Baron F; Ruggeri A; Beohou E; Labopin M; Sanz G; Milpied N; Michallet M; Bacigalupo A; Blaise D; Sierra J; Socié G; Cornelissen JJ; Schmid C; Giebel S; Gorin NC; Esteve J; Ciceri F; Savani BN; Mohty M; Gluckman E; Nagler A
Oncotarget; 2016 Jul; 7(28):43027-43038. PubMed ID: 27250025
[TBL] [Abstract] [Full Text] [Related]
20. Prediction of pediatric meningioma recurrence by preoperative MRI assessment.
Li H; Zhao M; Wang S; Cao Y; Zhao J
Neurosurg Rev; 2016 Oct; 39(4):663-9. PubMed ID: 27037557
[TBL] [Abstract] [Full Text] [Related]
[Next]
